Conference | RheumNow

Gout Review from EULAR2020

6 years 4 months ago

Dr. Olga Petryna reviews highlights from the virtual EULAR 2020 meeting June 3-6, 2020

Day 3 - Top 5 from EULAR 2020

Jack Cush, MD

6 years 4 months ago

These were my top abstracts from Thursday, 4th of June at EULAR 2020:

Year of the Wolf: Lupus at EULAR2020

Kathryn H. Dao, M.D.

6 years 4 months ago

For a disease that has been recognized since the days of Hippocrates, we are finally making some progress towards understanding systemic lupus erythematosus (SLE) and how to tame the wolf. Listed below are the top 5 studies and their summaries presented at the recent EULAR e-Congress conference streamed from Germany that I found impactful:

Serum calprotectin: a better biomarker in ANCA-associated vasculitis?

David Liew, FRACP

6 years 4 months ago

Flares in ANCA-associated vasculitis are difficult to predict, but serum calprotectin may help predict relapse and renal failure, according to data presented at the EULAR 2020 virtual meeting this week.

Day 2 – Top 5 from EULAR 2020

Jack Cush, MD

6 years 4 months ago

These were my top abstracts from Thursday, 4th of June at EULAR 2020.

Are we doing our best treating seronegative arthritides?

Olga Petryna, MD

6 years 4 months ago

Every time a big scientific meeting ends I ask myself a question: how is it going to affect the way I treat my patients? This year the question pertains to management of axial spondyloarthropathies and psoriatic arthritis. Actually, this question has been brewing for several years now, but only now we get more data to form more or less feasible answer. So let’s see what EULAR 2020 has to offer.